Tracking VERU? Get live short interest, options flow, and signals on ORTEX.Sign up free →
VE
Veru Inc. (VERU) short interest & options flow
NASDAQVERU reported fiscal Q2 2026 results today — and the numbers landed well ahead of a deeply pessimistic consensus. The headline fact is a significant earnings beat. Veru posted Q2 EPS of -$0.12, against an estimate of -$0.28. That is a 57% beat on the loss estimate, a meaningful outperformance for a clinical-stage biopharma where the Street had priced in considerably more cash burn…
$2.14+0.94% 1d-2.73% 1w-13.01% 1mClose: 11 Nov 2026
- Market cap
- $36M
- Next earnings
- 18 Dec 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 12 Nov 2026
VERU news and analysis
RSSNo long-form analysis yet for VERU. Pulse alerts and the live data picture are available on ORTEX.
Open VERU on ORTEX →Want the live picture for VERU?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VERU — free to start on ORTEX.
Sign up for free →Open VERU on ORTEX